
Please try another search
By Foo Yun Chee
BRUSSELS (Reuters) - A European court will decide on July 13 whether U.S. life sciences company Illumina (NASDAQ:ILMN)'s $8 billion cash-and-stock takeover of Grail should be scrutinised by EU antitrust regulators, people familiar with the matter said on Wednesday.
The case coincides with the European Commission seeking to expand its power to examine big companies' acquisitions of start-ups aimed at shutting down nascent rivals, with the focus on tech and pharma deals.
Critics call it a power grab that has even worried some national competition agencies.
The Luxembourg-based General Court, Europe's second-top court, declined to comment on the date of its ruling.
Illumina at a court hearing last year criticised the EU competition enforcer for using this rarely used power on a company with no activities in Europe.
"We believe the Commission wrongly asserted jurisdiction over a transaction between two American companies with no foreseeable impact on competition in Europe," Illumina said in an email.
The company announced the deal in September last year, which would give it access to Grail's flagship Galleri blood test used to diagnose cancers at early stages when the disease is easier to treat.
The case is T-227/21 Illumina v Commission.
(Reuters) - China Evergrande Group said on Tuesday a winding-up petition was filed against it by investment holding firm Top Shine Global Ltd in Hong Kong for not fulfilling a...
By Selena Li, Kane Wu and Julie Zhu HONG KONG (Reuters) -In 1997, the world watched as Britain returned Hong Kong to Chinese rule, with some pessimistic or wary about the outlook...
(Reuters) -Oklahoma has reached a $250 million settlement with AmerisourceBergen (NYSE:ABC) Corp, Cardinal Health Inc (NYSE:CAH) and McKesson Corp (NYSE:MCK) to resolve...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.